Who We Are
We are problems solvers and relentless discovers. We are passionate about creating simple tools that connect people to information they can use to make healthier decisions. Much like the individuals who use our products, we constantly ask questions, seek answers and find better ways to help people achieve the extraordinary.
Joe Kiani has ultimate oversight of the company’s marketing, product development, staffing and other key functions. Kiani’s other, primary role is running one of the world’s most admired medical technology companies, Masimo Corporation. Kiani founded Masimo in 1989 to improve the reliability of noninvasive patient monitoring. His vision first led Cercacor to bring the same technology it licenses to Masimo for use in hospitals worldwide to consumers via Ember – the world’s first non-invasive hemoglobin tracker for athletes. At his core, Kiani is an inventor of world-changing, noninvasive patient-monitoring devices and a trusted voice for patient safety and care. Under his leadership, Masimo has grown from a “garage start-up” into a successful, publicly traded company (NASDAQ: MASI) employing more than 3,500 people worldwide. Masimo provides its market-leading Masimo SET® Measure-through Motion and Low Perfusion pulse oximetry technology to leading patient-monitoring manufacturers throughout the world. Today, Masimo delivers key, noninvasive medical breakthroughs, including Rainbow Pulse CO-Oximetry™ – the first blood constituent monitoring platform to noninvasively measure multiple blood constituents. Rainbow Pulse CO-Oximetry™ incorporates Cercacor technologies to noninvasively measure carbon monoxide, methemoglobin and hemoglobin. In 2012, Kiani founded the nonprofit Patient Safety Movement Foundation to help eliminate the 200,000-400,000 annual, preventable patient deaths in U.S. hospitals. The Foundation’s yearly Patient Safety, Science & Technology Summit brings together many of the world’s leading clinicians, hospital CEOs, patient advocates and government leaders to identify challenges and provide tested solutions called Actionable Patient Safety Solutions (APSS). The Foundation publicly committed to the goal of zero preventable patient deaths by 2020 at the Clinton Global Initiative in 2013. The Foundation requested that attendees also make a formal and public patient safety commitment and report on it annually. To date, 1,200 hospitals have made a commitment. Kiani also serves on the board of directors of Children’s Hospital Orange County (CHOC).
Kevin pushes the frontier of device innovation, leading the company's discovery and rapid prototyping efforts. Foresight is driven by 10 years of experience in the medical device field involving spectroscopic systems, manufacturing development, and algorithm research. He joined Cercacor after receiving a B.S. from the University of California, Riverside Department of Bioengineering.
Gerry Hammarth joined Cercacor in 2013 as Chief Financial Officer. He is responsible for all financial and administrative operations of the company, bringing over 30 years of experience from various high growth industries. Prior to joining Cercacor, he served as Senior Vice President, Finance for Masimo Corporation. Hammarth holds an M.B.A. in Finance from the Wharton School of the University of Pennsylvania and a B.A. in Psychology from Stony Brook University.